Sangamo Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Sangamo Therapeutics has a total shareholder equity of $39.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $111.3M and $72.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$39.20m |
| Equity | US$39.13m |
| Total liabilities | US$72.13m |
| Total assets | US$111.26m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GBY's short term assets ($58.1M) exceed its short term liabilities ($43.2M).
Long Term Liabilities: GBY's short term assets ($58.1M) exceed its long term liabilities ($29.0M).
Debt to Equity History and Analysis
Debt Level: GBY is debt free.
Reducing Debt: GBY has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GBY has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if GBY has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.